sharing expertise session overview plan of action

sharing expertise session overview plan of action

1. MEDICAL / HEOR Sharing Expertise For LSM~ YD – Des 2024

2. https://www.linkedin.com/advice/0/what-your-best-tips-planning-preparing-training#define-your-goals Planning and preparing training sessions 1 Knowing your audience 2 Define goals 3 Choose the methods 4 Design activities 5 Prepare materials 6 Test and revise

3. Smarter Goals S - Specific M - Measurable A - Achievable R - Relevant T - Time-bound E - Expectations R - Resources

4. Method https://whatfix.com/blog/employee-training-methods/

5. OPSI 1 : Training by Expert (TBE) Menyesuaikan jadwal expert Cost speaker fee utk expert Langsung dari Specialist nya Cocok untuk New product (NCE) Suasana lebih serius dan merupakan momen engagement Kelebihan Kelemahan

6. OPSI 2 : Roleplay Perlu persiapan scenario Waktu yang lama dan pembagian jadwal kelompok yang kompleks Lebih aplikatif Spesifik dan menyesuaikan kebutuhan Impactful Kelebihan Kelemahan

7. OPSI 3 : Video Lecture Training Waktu pembuatan video lecture Akses upload video dengan kapasitas besar Simple. Provide more accessible Rekaman lecture dapat disimpan di tablet & dipelajari mandiri Memicu self-Learning Kelebihan Kelemahan

8. BEST SOLUTION : ? Based on necessity TBE Konsultasi budget dan agenda expert Roleplay Perlu persiapan dan cross functional collaboration Video E-Learning  Rekaman coaching / mentoring ( bekerjasama dengan IT untuk distribusi Video)

9. MSA & HEOR approach for Focus Product : Division Product to focus Remark Timeline HC – Basic Care ICS III Power app, first stick success campaign New Product - upcoming Closed system Cytoset group + MiniSPike HEOR study VS open system in oncology clinical setting Q2 - Q3 2025 Smart Infusion pump (with Drug Library) HEOR study VS conventional After Local Production AVITUM Advance Care NEXADIA (Monitor for HD Machine) HEOR study, Power app implementation New Product - upcoming CRRT (OMNI) clinical pathway – Cost effectiveness (VS IHD AKI in ICU) New Product - upcoming Pencan HEOR study VS conventional to reduce PDPH New Product - upcoming Nutrimix , Sterofundin VS WFI Cost effectiveness (VS conventional) Q2 - Q3 2025 Prilocaine ( Takipril ) scientific (guideline) for National formulary listing Q2 2025 AESCULAP DCB (Sequent please Neo) HEOR study , Top up reimbursement Q3 2024 - Q1 2025 Histoacryl ( Lapfix + Blue) AP Hernia study, local Real-world data Q3 2024 - Q2 2025

10. Medical / HEOR Sharing Session 2025 TIMELINE ACTIVITY REMARKS JANUARY DCB - Journal Reading : Refreshment current studies, RECAGFREE trial  AESCULAP IVT FEBRUARY HERNIA MESH FIXATION - Journal Reading : Histoacryl VS other fixation  AESCULAP OR Supply MARCH PRILOCAINE - Journal overviews : Safety and Efficacy Prilocaine  HC- ADVANCE APRIL CRRT : Indication, recent guideline, and recommendation  HC- ADVANCE  MAY HEOR study : PENCAN VS Spinocan (conventional) to reduce PDPH  HC- ADVANCE  JUNE ICS III : first stick success campaign  HC- BASIC JULY DCB - sharing discussion, Q&A, handling objection  AESCULAP IVT AUGUST HERNIA MESH FIXATION -sharing discussion, Q&A, handling objection AESCULAP OR Supply  SEPTEMBER PRILOCAINE - sharing discussion, Q&A, handling objection  HC- ADVANCE OCTOBER Power app socialization : AICON (Sterile container) ASCULAP NOVEMBER Power app socialization : SMART INFUSION PUMP HC- BASIC   DECEMBER Power app socialization & Value tools in Health Technology for focus product All Marketing division 

11. Medical Training Schedule FY 2023 TEAM January February March April May June July August September October November Desember SPECTRA 10 jan Epilepsy, Seizure, & LEVEXA oral (pre post test Live Quiziz ) 1 Feb Anticoagulan : APIXABAN (pre post test Live Quiziz ) 16 Mar Sharing discussion & Q-A LEVEXA + SITAZIT, DAPAZOX, APRIXA (oral explanation)   5 May Sharing discussion, and keypoint SITAZIT, APRIXA 5 June APRIXA (Apixaban) (Q&A discussion) 7 June LEVEXA study Sharing discussion, 24 July APRIXA & IRBESARTAN KONAS -prep 28 July LEVEXA IV (post test via google form) 22-25 Aug ANTIPSYCHOTIC (Spectra CNS) DAPAZOX, SITAZIT (Spectra CVM) (post test via google form with days limit) 21-24 Sep LEVEXA (Spectra CNS) APROXA (Spectra CVM) (post test via google form with days limit) 3 Oct DAPAZOX (Dapagliflozin) (post test via google form with days limit) 16 Nov LEVEXA INJ (Live Quiz google form with time limit : 7 minute) ONCOLOGY 11 jan Clinical Study BEVAAS (pre post test Live Quiziz)   15 Mar Sharing discussion & Q-A EXAMEST (Examestane)   17 May EXAMEST (post test via google form with days limit)   20 July Clinical Study BEVAAS (post test via google form with days limit) 22-25 Aug BEVAAS and EXAMEST (post test via google form with days limit) 1 Sep & 19 Sep mCRC : BEVAAS & IRITERO summary PreJDW & sharing discussion 19 Oct EXAMEST (Live Quiz google form with time limit : 5 minute) 1 Nov NILTIB (Live interaction Q&A discussion)   HOSPICARE   2 Feb: induction All antimicrobial (VORICA, VALGOVIR, VANCONEX, LINETERO, MOXICIN) 14 Mar Sharing discussion & Q-A All product Hospicare , focus on SOGOMA (pre post test Live Quiziz ) Sharing discussion , 5 Apr VANCONEX/ LINETERO in Obgyn 14 Apr VANCONEX/ LINETERO in SSTI 10 May VANCONEX, LINETERO, SOGOMA (post test via google form with days limit) 2 June Sharing discussion, and keypoint SOGOMA 20 July Sharing discussion, and keypoint VORICA in febrile netropenia , VANCONEX, LINETERO 22-25 Aug ALL HOSPICARE product (post test via google form with days limit) 5 Sept SOGOMA & VANCONEX (interactive quiz sent by E-mail) 5 Oct TAFNEXT & VALGOVIR 20 Oct MOXIFLOXACIN & fluoroquinolone (interactive Q&A) 7 Nov VORICA in febril neutropenia / malignancy patient (sharing & discussion BHOM slide) ALL (CD / Non CD, Factory) PHARMACOVIGILANCE TRAINING minimal 2X/ FY (existing employee & New employee induction PV overview) 3 April : ONCO & HOSPICARE training PV 4 April : SPECTRA training PV (Pre post test with google from)

12. Questionnaire Result (data by July 2023) – 85 Korespondensi , Divisi Hospicare , Onco , Spectra Medical Training ~insight from Sales and Marketing team 

13. Point to implemented Training perlu dilakukan secara tatap muka untuk produk baru Training dilakukan secara rutin (1-2 x/ bulan ) Teknis dilakukan : penjelasan dari medical lalu dilanjutkan dengan diskusi tanya jawab Waktu sebaiknya di pagi hari dengan durasi 1-2 jam Metode Evaluasi dilakukan secara Live (real time) Keunggulan produk berdasarkan study dan Evidence Based menjadi topik yang paling penting

14. Beberapa Komentar / Saran / Kritik   untuk sesi medical training ke depannya

15. Method  Need to Prepare based on Priority scale Necessity / Urgently Needed Timing Cross Function Collaboration (discuss with mentor, PM, Sales)

16. THANK YOU ! 